Opening the book…
Medicalization is the process by which ordinary human experiences are redefined as medical problems, and women's reproductive functioning has been a recurring target. Over the twentieth century, birth moved out of the home and away from midwives into hospitals under obstetric management, and routine intervention became the norm. One marker is the cesarean section (C-section; surgical delivery of a baby through abdomen) rate, which has climbed worldwide from about 7 percent in 1990 to roughly 21 percent today, well above the 10 to 15 percent the World Health Organization associates with the best outcomes, and it is projected to keep rising (Angolile et al., 2023). To be clear, C-sections and other interventions do save lives when they are medically indicated. Some of the rise reflects real changes in who gives birth, as mothers are older and heavier on average and more have had a prior cesarean (de Vries et al., 2021). But much of it does not track medical need. Private hospitals perform far more cesareans than public ones serving similar women, rates shift when the fees paid to doctors change, and both fear of a lawsuit and the convenience of a scheduled delivery push toward surgery (Ojong et al., 2026; Opiyo et al., 2020). A cesarean is also self-perpetuating, since one surgery commits most women to the same surgery in every later birth (Grantz et al., 2025). The concern is their routine use in low-risk births, where they can add harm without benefit. For low-risk pregnancies, a meta-analysis of 1.4 million births found that midwife-led care produced fewer C-sections, instrumental deliveries, epidurals, and episiotomies, with shorter hospital stays and maternal and newborn outcomes that were comparable or better (Sriram et al., 2024), a pattern that holds even in randomized trials, which balance risk between the groups (Sandall et al., 2024). For a low-risk pregnancy, more medical management does not reliably produce a safer birth.
For Black women, obstetrics has a far more disturbing history. Recall from Section 11.3 that even today Black women’s pain and experiences are routinely dismissed and as a result, they die of pregnancy-related causes far more often. That racist approach to Black women's reproductive bodies is what this chapter's epigraph highlights, but it is not limited to modern times. The control of Black women's reproduction has a long and documented history in the United States. Under slavery, enslaved women's fertility was treated as the property of slaveholders, and their capacity to bear children was turned into a source of profit (Adekunle, 2025; Prather et al., 2018). In the 1840s the physician J. Marion Sims, later celebrated as a father of American gynecology, developed his surgical techniques by operating repeatedly on enslaved women without anesthesia, on the racist premise that Black patients did not feel pain the way white patients did (Hill, 2020). Three of these women are known to us by name, Anarcha, Lucy, and Betsey. They are now honored in the Mothers of Gynecology monument, a sculpture created by the artist and activist Michelle Browder and unveiled in Montgomery, Alabama, in 2021, which works to return identity to women whom nineteenth-century medicine recorded only as experimental subjects. In the twentieth century the aim shifted from compelling reproduction to preventing it, as eugenic and coerced sterilization programs disproportionately targeted Black women. The practice was common enough in parts of the South to earn the grim nickname "Mississippi appendectomy," and the voting-rights organizer Fannie Lou Hamer was among those sterilized without her consent (Smaw, 2021). This history helps put into context the medical mistrust many Black women carry into the healthcare system today (Adekunle, 2025; Prather et al., 2018).
Control of women's bodies does not always take such horrific forms. The medicalization of premenstrual symptoms is a smaller-scale example. The 2013 addition of premenstrual dysphoric disorder (PMDD) to the DSM-5 was controversial (Schroll et al., 2022). For some, a formal diagnosis validates genuine, sometimes debilitating suffering and unlocks access to treatment. PMDD is actually quite narrowly defined. It requires several severe mood and physical symptoms, confirmed by tracking across two cycles, that cause genuine functional impairment akin to major depression. By that standard it affects only a small minority, roughly 2 to 6 percent of menstruating people (Reilly et al., 2024). Relax the criteria and estimated prevalence can climb toward 20 percent, folding ordinary premenstrual experience into a disorder (Cirillo et al., 2014). The fear is that treating the ordinary cycle as a disorder frames women's bodies as chronically dysfunctional, feeds the old stereotype of the premenstrual woman as irrational and unfit to lead, and erases the neutral or positive changes many women report across the cycle (King & Ussher, 2013). Against the strict diagnosis, however, that worry about pathologizing the cycle has much less force. Whether fear is justified comes down to where medicine draws that line, and who is served by drawing it narrowly. The same medical authority to define a normal process, and to flag departures from it as disorders, shapes the care available to trans women.
Section Key Terms
This page titled 11.4: The Medicalization of Reproductive Health was last modified on Fri, 11 Sep 2026 19:01:08 GMT and is shared under a CC BY-NC-SA 4.0 license and was authored, remixed, and/or curated by Rochelle Burnaford.
The book could not be loaded just now.